be sent December 4. Late-breaking abstracts will be accepted from November 28-December 8. Fellows, nurses, and advanced practice providers are encouraged to submit abstracts for oral presentation and be considered for a travel grant. Visit /abstracts. Pricing and Hotel Reservations Avoid the commute and stay at the ARIA. Visit for pricing and hotel details. CONTINUING MEDICAL EDUCATION/MAINTENANCE OF CERTIFICATION See complete CME and MOC information online. Use #CCCongress to tag your posts, interact and read the must-attend meeting for all inflammatory bowel disease (IBD) professionals. Build a powerful network and share solutions with thought-leaders in IBD. Learn together as one multidisciplinary care team. Improve skills and patient outcomes. Explore new technologies and products from IBD-related exhibitors. the strengths of the nation s leading IBD patient organization, Crohn s & Colitis Foundation, and the premier GI professional association, AGA. Together we are committed to convening foremost practitioners and investigators in The Crohn s & Colitis Foundation and AGA are honored to work with the Crohn s & Colitis D. Brent Polk, MD, AGAF discoveries in IBD with the top leaders in the field. Submit for oral and/or poster presentation for free. The processing fee for the inaugural year of be co-published in AGA s journal Gastroenterology and the Crohn s & Colitis Meet researchers and clinicians and discover new opportunities for research Crohn s & Colitis Congress Event IBD The Crohn s & Colitis Congress is supported by educational grants from Salix Pharmaceuticals and Takeda Pharmaceuticals U.S.A., Inc. Expand your knowledge, network leaders, spark innovative research and get inspired to improve patient care.
Crohn s & Colitis Congress General Sessions Session I: s Case 1: Psychosocial Care of the IBD Patient: Treating Depression Case 2: Diet as a Therapy in IBD Case 1: The Adolescent and Young Adult Case 2: The Flaring Pregnant Patient C: Management of Perianal and Pouch Complications Case 1: Complications of the Pouch Case 2: Management of Perianal Disease Session II: 1:55 5:30 IBD p.m. 1:55 Keynote Clinical : Incorporating New Therapies into Abstract the must-attend meeting for all inflammatory bowel disease (IBD) professionals. Keynote Research : Biomarkers for Precision Medicine Speaker: Build a Lee powerful A. Denson, network MDand share solutions with Abstract thought-leaders in IBD. Multidisciplinary Learn together as Panel one Review multidisciplinary of Cases care team. Panel: Alessandro Fichera, MD, Jeffrey Hyams, MD, Kelly Issokson, MD, RD, Case 1: 18-Year Old Patient with Newly Diagnosed Mild to Moderate Improve Complicated skills and Disease patient outcomes. Explore Case new 2: When technologies to Treat with and products Another Biologic from IBD-related vs. Going exhibitors. Surgery to the strengths of A: the Research nation s That leading Will IBD Guide patient Your organization, Practice, Crohn s Not Tomorrow, & Colitis But Foundation, Soon and the premier GI professional association, AGA. Together we Moderators: are committed TBA to convening foremost practitioners and investigators in Predictors of Immune Response: How to Decide Which Therapy Fecal Metabolomic The Crohn s Analysis: & Colitis Ready Foundation for Clinical and AGA Use? are Speaker: Jonathan honored to Braun, work MD, with PhD, the Crohn s AGAF& Colitis B: Challenges in Monitoring Response Moderators: Adam D. Brent Cheifetz, Polk, MD, MD, AGAF AGAF and Fabio Cominelli, MD, PhD Proactive Therapeutic Drug Monitoring For Whom and How Asymptomatic but Ongoing Inflammation What Now and Does Age Matter?
Crohn s & Colitis Congress General Sessions Session I: Session II: 1:55 Crohn s & Colitis Congress Event Session III: 8 a.m. noon Saturday, January 20, and 2018 Meet researchers and clinicians discover new opportunities for research 1:55 Session III: Clinical and Research Challenges 8:00 a.m. noon Moderator: TBA Keynote Clinical : Incorporating New Therapies into Keynote Research : Biomarkers for Precision Medicine Speaker: Lee A. Denson, MD s Case 1: Psychosocial Care of the IBD Patient: Treating Depression Case 2: Diet as a Therapy in IBD Case 1: The Adolescent and Young Adult Case 2: The Flaring Pregnant Patient C: Management of Perianal and Pouch Complications Case 1: Complications of the Pouch Case 2: Management of Perianal Disease Multidisciplinary Panel Review of Cases Panel: Alessandro Fichera, MD, Jeffrey Hyams, MD, Kelly Issokson, MD, RD, Case 1: 18-Year Old Patient with Newly Diagnosed Mild to Moderate Complicated Disease Case 2: When to Treat with Another Biologic vs. Going to Surgery to A: Research That Will Guide Your Practice, Not Tomorrow, But Soon Moderators: TBA Predictors of Immune Response: How to Decide Which Therapy Fecal Metabolomic Analysis: Ready for Clinical Use? Speaker: Jonathan Braun, MD, PhD, AGAF B: Challenges in Monitoring Response Moderators: Adam Cheifetz, MD, AGAF and Fabio Cominelli, MD, PhD Proactive Therapeutic Drug Monitoring For Whom and How Thursday, January 18, 2018 (may require additional registration fees) Devote a day or an afternoon to in-depth learning on topics that will be sure to inspire you. See Workshop agendas and costs at /workshops. Quick Shot in Breakouts Abstract Breakout Sessions discoveries IBD with the top leaders in the field. Submit for oral and/or poster presentation for free. The processing fee for the inaugural year of A: Basic be co-published in AGA s journal Gastroenterology and the Crohn s & Colitis B: Clinical A: Translational Research be sent December 4. Late-breaking abstracts will be accepted from Moderators: D. Brent8.Polk, MD, AGAF and David Rubin, MD, AGAF November 28-December 1: Engineering the Gut Environment for the Treatment of IBD (Diet and Microbiome) as Short-to-Intermediate Deliverable Speaker: D. Wu, MD Fellows, nurses,gary and advanced practice providers are encouraged to submit abstracts for oral presentation and be considered for a travel grant. Visit 2: Advancing Findings in Immunology /abstracts. Speaker: Clara Abraham, MD B: Clinical Challenges You Face Every Day Pricing and Hotel Reservations Moderators: Robert Burakoff, MD, MPH, AGAF and Philip Paul Minar, MD Panel: Park, MD, M. ARIA. Szigethy, MD, PhD and Douglas Wolf, MD Avoid the KT commute andms, stayeva at the Visit for pricing and hotel details. Case 1: How do we Reduce Narcotic Use? CONTINUING MEDICAL Case 2: Access toeducation/maintenance Care: How to Get the Care OF thecertification Patient Needs See complete CME and MOC information online. Findings in Epithelial Keynote Research : Advancing Biology and Immune/Epithelial Interactions to Improve Mucosal Healing Speaker: Thaddeus Stappenbeck, MD, PhD, AGAF Use #CCCongress to tag your posts, interact and read Abstract Keynote Clinical : Treating the Refractory Patient and Raising the Bar for IBD Outcomes Speaker: Peter Higgins, MD, PhD Highlight of the Year: Clinical and Basic Research Speaker: Bruce Sands, MD, MS, AGAF Perspectives: IBD Review for Professionals 8:00 a.m. 4:00 p.m. Moderators: Francis A. Farraye, MD, MSc and Gary Lichtenstein, MD, AGAF For community gastroenterologists, gastroenterology nurse practitioners, physician assistants, hospital pharmacists and managed care directors. Leading experts will provide a comprehensive overview of Crohn s disease and ulcerative colitis through presentations on causes, diagnosis, medical and surgical management, health maintenance, and risks of therapies. Attendees will also have the opportunity to participate in an interactive case-based session. Clinician s Guide to Fecal Microbiota Transplantation (FMT) 8:30 a.m. 4:45 p.m. Moderator: Gail Hecht, MD, MS, AGAF For practicing gastroenterologists and other health-care providers interested in learning about the past, present and future of fecal microbiota transplantation (FMT) as an intervention for intractable GI conditions such as IBD. This full-day program will discuss the state of the science, regulatory considerations and status of FMT-inspired therapeutics under development. Cutting-Edge Pediatric IBD 1:00 5:00 p.m. Moderators: Michael Kappelman, MD, MPH and Neera Gupta, MD, MAS For all providers who care for pediatric patients. This half-day workshop will address emerging concepts highly relevant to the clinical management of children and young adults. Managing IBD for Optimal Patient Care (For IBD nurses and advanced practice providers) 1:00 5:00 p.m. Moderator: Maureen Kelly, MS This half-day workshop will address the latest information on Crohn s disease and ulcerative colitis with a particular focus on personalization of care. The Lloyd Mayer, MD Young IBD Investigators Clinical, Basic, and Translational Research Workshop 1:00 5:00 p.m. Moderator: Florian Rieder, MD and Karen Chachu, MD, PhD Closing Remarks Note: Agenda and speakers are subject to change. Asymptomatic but Ongoing Inflammation What Now and Does Age Matter? Pre-Congress Workshops This free workshop is targeted to early career clinical, basic and translational researchers as well as senior researchers. It will feature a mix of research presentations by young investigator colleagues, keynote presentations, and panel discussion with established IBD researchers. The theme this year is focused around grant proposal and will include two mock grant review sessions.
Crohn s & Colitis Congress General Sessions Session I: Session II: 1:55 Session III: 8 a.m. noon s Case 1: Psychosocial Care of the IBD Patient: Treating Depression Case 2: Diet as a Therapy in IBD Case 1: The Adolescent and Young Adult Case 2: The Flaring Pregnant Patient C: Management of Perianal and Pouch Complications Case 1: Complications of the Pouch Case 2: Management of Perianal Disease 1:55 Keynote Clinical : Incorporating New Therapies into Keynote Research : Biomarkers for Precision Medicine Speaker: Lee A. Denson, MD Multidisciplinary Panel Review of Cases Panel: Alessandro Fichera, MD, Jeffrey Hyams, MD, Kelly Issokson, MD, RD, Case 1: 18-Year Old Patient with Newly Diagnosed Mild to Moderate Complicated Disease Case 2: When to Treat with Another Biologic vs. Going to Surgery to A: Research That Will Guide Your Practice, Not Tomorrow, But Soon Moderators: TBA Predictors of Immune Response: How to Decide Which Therapy Fecal Metabolomic Analysis: Ready for Clinical Use? Speaker: Jonathan Braun, MD, PhD, AGAF B: Challenges in Monitoring Response Moderators: Adam Cheifetz, MD, AGAF and Fabio Cominelli, MD, PhD Proactive Therapeutic Drug Monitoring For Whom and How Asymptomatic but Ongoing Inflammation What Now and Does Age Matter? Saturday, January 20, 2018 Session III: Clinical and Research Challenges 8:00 a.m. noon Moderator: TBA Quick Shot Breakouts A: Basic B: Clinical A: Translational Research Moderators: D. Brent Polk, MD, AGAF and David Rubin, MD, AGAF 1: Engineering the Gut Environment for the Treatment of IBD (Diet and Microbiome) as Short-to-Intermediate Deliverable Speaker: Gary D. Wu, MD 2: Advancing Findings in Immunology Speaker: Clara Abraham, MD B: Clinical Challenges You Face Every Day Moderators: Robert Burakoff, MD, MPH, AGAF and Philip Paul Minar, MD Panel: KT Park, MD, MS, Eva M. Szigethy, MD, PhD and Douglas Wolf, MD Case 1: How do we Reduce Narcotic Use? Case 2: Access to Care: How to Get the Care the Patient Needs Keynote Research : Advancing Findings in Epithelial Biology and Immune/Epithelial Interactions to Improve Mucosal Healing Speaker: Thaddeus Stappenbeck, MD, PhD, AGAF Keynote Clinical : Treating the Refractory Patient and Raising the Bar for IBD Outcomes Speaker: Peter Higgins, MD, PhD Highlight of the Year: Clinical and Basic Research Speaker: Bruce Sands, MD, MS, AGAF Closing Remarks Note: Agenda and speakers are subject to change. Pre-Congress Workshops Thursday, January 18, 2018 (may require additional registration fees) Devote a day or an afternoon to in-depth learning on topics that will be sure to inspire you. See Workshop agendas and costs at /workshops. Perspectives: IBD Review for Professionals 8:00 a.m. 4:00 p.m. Moderators: Francis A. Farraye, MD, MSc and Gary Lichtenstein, MD, AGAF For community gastroenterologists, gastroenterology nurse practitioners, physician assistants, hospital pharmacists and managed care directors. Leading experts will provide a comprehensive overview of Crohn s disease and ulcerative colitis through presentations on causes, diagnosis, medical and surgical management, health maintenance, and risks of therapies. Attendees will also have the opportunity to participate in an interactive case-based session. Clinician s Guide to Fecal Microbiota Transplantation (FMT) 8:30 a.m. 4:45 p.m. Moderator: Gail Hecht, MD, MS, AGAF For practicing gastroenterologists and other health-care providers interested in learning about the past, present and future of fecal microbiota transplantation (FMT) as an intervention for intractable GI conditions such as IBD. This full-day program will discuss the state of the science, regulatory considerations and status of FMT-inspired therapeutics under development. Cutting-Edge Pediatric IBD 1:00 5:00 p.m. Moderators: Michael Kappelman, MD, MPH and Neera Gupta, MD, MAS For all providers who care for pediatric patients. This half-day workshop will address emerging concepts highly relevant to the clinical management of children and young adults. Managing IBD for Optimal Patient Care (For IBD nurses and advanced practice providers) 1:00 5:00 p.m. Moderator: Maureen Kelly, MS This half-day workshop will address the latest information on Crohn s disease and ulcerative colitis with a particular focus on personalization of care. The Lloyd Mayer, MD Young IBD Investigators Clinical, Basic, and Translational Research Workshop 1:00 5:00 p.m. Moderator: Florian Rieder, MD and Karen Chachu, MD, PhD This free workshop is targeted to early career clinical, basic and translational researchers as well as senior researchers. It will feature a mix of research presentations by young investigator colleagues, keynote presentations, and panel discussion with established IBD researchers. The theme this year is focused around grant proposal and will include two mock grant review sessions.
be sent December 4. Late-breaking abstracts will be accepted from November 28-December 8. Fellows, nurses, and advanced practice providers are encouraged to submit abstracts for oral presentation and be considered for a travel grant. Visit /abstracts. Pricing and Hotel Reservations Avoid the commute and stay at the ARIA. Visit for pricing and hotel details. CONTINUING MEDICAL EDUCATION/MAINTENANCE OF CERTIFICATION See complete CME and MOC information online. Use #CCCongress to tag your posts, interact and read the must-attend meeting for all inflammatory bowel disease (IBD) professionals. Build a powerful network and share solutions with thought-leaders in IBD. Learn together as one multidisciplinary care team. Improve skills and patient outcomes. Explore new technologies and products from IBD-related exhibitors. the strengths of the nation s leading IBD patient organization, Crohn s & Colitis Foundation, and the premier GI professional association, AGA. Together we are committed to convening foremost practitioners and investigators in The Crohn s & Colitis Foundation and AGA are honored to work with the Crohn s & Colitis D. Brent Polk, MD, AGAF discoveries in IBD with the top leaders in the field. Submit for oral and/or poster presentation for free. The processing fee for the inaugural year of be co-published in AGA s journal Gastroenterology and the Crohn s & Colitis Meet researchers and clinicians and discover new opportunities for research Crohn s & Colitis Congress Event IBD The Crohn s & Colitis Congress is supported by educational grants from Salix Pharmaceuticals and Takeda Pharmaceuticals U.S.A., Inc. Expand your knowledge, network leaders, spark innovative research and get inspired to improve patient care.